Our mission is to conduct rigorous and high-quality scientific research that advances our understanding of medicine and improves the quality of healthcare.
Our Work
At Syon Biosciences, we specialize in developing small-molecule drugs designed to target proteins implicated in cancer and inflammatory diseases. Our research focuses on identifying key proteins involved in the expression of these conditions and creating novel molecules to effectively inhibit their function. Through innovative drug development, we aim to advance therapeutic options and improve patient outcomes.
Current Projects
Dihydrofolate Reductase (DHFR) is an enzyme crucial for DNA synthesis. DHFR inhibitors can prevent the growth of cancer cells, offering a promising approach for cancer treatment.
Nuclear Factor kappa B (NF-κB) is a protein complex that plays a key role in regulating the immune response and inflammation. NF-κB inhibitors can reduce inflammation and hinder the progression of cancer.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain relief and inflammation reduction. Our latest research introduces novel methods to enhance NSAID stability and absorption, promising more effective and longer-lasting relief.
Research Areas
Biotechnology
Drug
Discovery
Proteonomics
Medicinal
Chemistry
More About Us
At Syon Biosciences, we are at the forefront of biotechnology, leveraging multidicipilniary experience to develop groundbreaking therapeutics. Our team designs and synthesizes novel compounds with precision and efficiency. We analyze protein interactions and pathways to understand disease mechanisms better. Our biotechnological capabilities enable us to translate these insights into effective treatments. Together, we're working towards our mission to transform medical research into impactful healthcare solutions.
